D-Wave Quantum (NYSE:QBTS) and Clarivate (NYSE:CLVT) Head to Head Survey
Posted by Defense World Staff on Dec 26th, 2022
D-Wave Quantum (NYSE:QBTS – Get Rating) and Clarivate (NYSE:CLVT – Get Rating) are both computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.
Insider and Institutional Ownership
10.4% of D-Wave Quantum shares are owned by institutional investors. Comparatively, 87.3% of Clarivate shares are owned by institutional investors. 14.6% of D-Wave Quantum shares are owned by insiders. Comparatively, 24.9% of Clarivate shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Earnings and Valuation
This table compares D-Wave Quantum and Clarivate’s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| D-Wave Quantum | N/A | N/A | $24.25 million | N/A | N/A |
| Clarivate | $1.88 billion | 2.93 | -$270.45 million | ($6.84) | -1.19 |
D-Wave Quantum has higher earnings, but lower revenue than Clarivate.
Analyst Ratings
This is a summary of current ratings and target prices for D-Wave Quantum and Clarivate, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| D-Wave Quantum | 0 | 0 | 3 | 0 | 3.00 |
| Clarivate | 0 | 2 | 4 | 0 | 2.67 |
D-Wave Quantum currently has a consensus price target of $8.00, suggesting a potential upside of 370.59%. Clarivate has a consensus price target of $14.25, suggesting a potential upside of 74.63%. Given D-Wave Quantum’s stronger consensus rating and higher possible upside, equities analysts plainly believe D-Wave Quantum is more favorable than Clarivate.
Profitability
This table compares D-Wave Quantum and Clarivate’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| D-Wave Quantum | N/A | -31.40% | -7.22% |
| Clarivate | -172.68% | 6.23% | 3.02% |
Risk and Volatility
D-Wave Quantum has a beta of -1.21, meaning that its share price is 221% less volatile than the S&P 500. Comparatively, Clarivate has a beta of 0.95, meaning that its share price is 5% less volatile than the S&P 500.
Summary
Clarivate beats D-Wave Quantum on 7 of the 11 factors compared between the two stocks.
About D-Wave Quantum
D-Wave Quantum Inc. develops and delivers quantum computing systems, software, and services worldwide. The company offers Advantage, a fifth-generation quantum computer; Launch, a quantum computing onboarding service; Ocean a full suite of open-source programming tools; and Leap, a cloud-based service that provides real-time access to a live quantum computer, as well as access to Advantage, hybrid solvers, the Ocean software development kit, live code, demos, learning resources, and a vibrant developer community. It also provides D-Wave Launch, a quantum professional service that guides enterprises from problem discovery through in-production application deployment. The company's quantum solutions are used in artificial intelligence, materials sciences, drug discovery, scheduling, cybersecurity, fault detection, and financial modeling. It serves manufacturing and logistics, financial services, life sciences, and other industries. D-Wave Quantum Inc. is based in Burnaby, Canada.
About Clarivate
Clarivate Plc, an information services and analytics company, provides structured information and analytics for discovery, protection, and commercialization of scientific research, innovations, and brands. It offers Web of Science products and services, such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio to organizations that plan, fund, implement, and utilize research; and Life Sciences products, including Cortellis and Newport Integrity for pharmaceutical and biotechnology companies to support research, market intelligence, and competitive monitoring in connection with the development and commercialization of new drugs. The company also provides Derwent products, which include Derwent Innovation, Techstreet, and IP Professional Services that enables its customers to evaluate the novelty of potential new products, confirm freedom to operate with respect to their product design, help them secure patent protection, assess the competitive technology landscape, and ensure that their products comply with required industry standards; CompuMark products, such as trademark screening, searching, and watching products and services for businesses and law firms; and MarkMonitor products, which helps enterprises to establish, manage, optimize, and protect their online presence. It serves government and academic institutions, life science companies, and research and development corporations in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc is headquartered in London, the United Kingdom.
Receive News & Ratings for D-Wave Quantum Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for D-Wave Quantum and related companies with MarketBeat.com's FREE daily email newsletter.
You might be interested in:
Analysts Set OrganiGram Holdings Inc. Price Target at C$2.33
Aviva plc Given Average Rating of “Moderate Buy” by Brokerages
Intra-Cellular Therapies, Inc. Receives Average Recommendation of “Moderate Buy” from Analysts
Yamana Gold Inc. Receives Average Rating of “Moderate Buy” from Brokerages
Microsoft Co. Receives Average Rating of “Moderate Buy” from Brokerages
H.B. Fuller Given Consensus Rating of “Hold” by Brokerages



